These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 24814894)

  • 1. Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. a systematic review.
    Giannakoulas G; Mouratoglou SA; Gatzoulis MA; Karvounis H
    Int J Cardiol; 2014 Jul; 174(3):618-23. PubMed ID: 24814894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
    Li G; Li Y; Tan XQ; Jia P; Zhao J; Liu D; Wang T; Liu B
    Pediatr Cardiol; 2017 Dec; 38(8):1620-1626. PubMed ID: 28819713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron deficiency in pulmonary arterial hypertension associated with congenital heart disease.
    Yu X; Zhang Y; Luo Q; Liu Z; Zhao Z; Zhao Q; Gao L; Jin Q; Yan L
    Scand Cardiovasc J; 2018 Dec; 52(6):378-382. PubMed ID: 30632395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
    Thakkar V; Stevens W; Prior D; Rabusa C; Sahhar J; Walker JG; Roddy J; Lester S; Rischmueller M; Zochling J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):129-136. PubMed ID: 27214686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Plasma Connective Tissue Growth Factor Levels in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
    Li G; Tang L; Jia P; Zhao J; Liu D; Liu B
    Pediatr Cardiol; 2016 Apr; 37(4):714-21. PubMed ID: 26714814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric Dimethyl-L-Arginine is a Biomarker for Disease Stage and Follow-Up of Pulmonary Hypertension Associated with Congenital Heart Disease.
    Fang ZF; Huang YY; Tang L; Hu XQ; Shen XQ; Tang JJ; Zhou SH
    Pediatr Cardiol; 2015 Jun; 36(5):1062-9. PubMed ID: 25737007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
    Chung L; Fairchild RM; Furst DE; Li S; Alkassab F; Bolster MB; Csuka ME; Derk CT; Domsic RT; Fischer A; Frech TM; Gomberg-Maitland M; Gordon JK; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TAJ; Molitor JA; Preston IR; Schiopu E; Shapiro L; Hant F; Silver R; Simms R; Varga J; Steen VD; Zamanian RT
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):106-113. PubMed ID: 27908301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric Dimethylarginine and NT-proBNP Levels Provide Synergistic Information in Pulmonary Arterial Hypertension.
    Shafran I; Probst V; Panzenböck A; Sadushi-Kolici R; Gerges C; Wolzt M; Segel MJ; Celermajer DS; Lang IM; Skoro-Sajer N
    JACC Heart Fail; 2024 Jun; 12(6):1089-1097. PubMed ID: 38573264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
    Cavagna L; Caporali R; Klersy C; Ghio S; Albertini R; Scelsi L; Moratti R; Bonino C; Montecucco C
    J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of ADMA in patients with pulmonary arterial hypertension combination with congenital heart disease].
    Chen P; Huang Y; Fang Z; Hu X; Shen X; Zhou S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 42(1):35-40. PubMed ID: 28216495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension.
    Daly CM; Griffiths M; Simpson CE; Yang J; Damico RL; Vaidya RD; Williams M; Brandal S; Jone PN; Polsen C; Ivy DD; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Nies MK; Rosenzweig EB; Hirsch R; Yung D; Everett AD
    J Am Heart Assoc; 2021 Oct; 10(20):e021409. PubMed ID: 34622662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell distribution width in addition to N-terminal prohormone of B-type natriuretic peptide concentration improves assessment of risk of cardiovascular events in adult patients with congenital heart disease.
    Martínez-Quintana E; Estupiñán-León H; Riaño-Ruiz M; Rodríguez-González F; Tugores A
    Arch Cardiovasc Dis; 2020 Oct; 113(10):607-616. PubMed ID: 33039325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cystatin C as a biomarker for prognosis in pulmonary arterial hypertension due to congenital heart disease.
    Blok IM; van Riel AC; Schuuring MJ; de Bruin-Bon RH; van Dijk AP; Hoendermis ES; Zwinderman AH; Mulder BJ; Bouma BJ
    Int J Cardiol; 2016 Apr; 209():242-7. PubMed ID: 26897077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated homocysteine and asymmetric dimethyl arginine levels in pulmonary hypertension associated with congenital heart disease.
    Sanli C; Oguz D; Olgunturk R; Tunaoglu FS; Kula S; Pasaoglu H; Gulbahar O; Cevik A
    Pediatr Cardiol; 2012 Dec; 33(8):1323-31. PubMed ID: 22526220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Connective Tissue Growth Factor as a Biomarker of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Adults.
    Liu W; Hua Y; Zheng D; Lv W; Zhang W; Chen Q; Huang R; Li X
    Circ J; 2023 Mar; 87(4):527-535. PubMed ID: 36843115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
    Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
    Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of iloprost on biomarkers in patients with congenital heart disease-pulmonary arterial hypertension.
    Li XY; Zheng Y; Long Y; Zhang X; Zhang L; Tian D; Zhou D; Lv QZ
    Clin Exp Pharmacol Physiol; 2017 Sep; 44(9):914-923. PubMed ID: 28608969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
    Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
    Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension.
    Al-Naamani N; Palevsky HI; Lederer DJ; Horn EM; Mathai SC; Roberts KE; Tracy RP; Hassoun PM; Girgis RE; Shimbo D; Post WS; Kawut SM;
    Ann Am Thorac Soc; 2016 Jan; 13(1):25-30. PubMed ID: 26501464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating High Mobility Group Box-1 Does Not Predict Pulmonary Arterial Hypertension in Children with Congenital Heart Disease: A Prospective Cohort Study.
    Caracci B; Pehora C; Benson L; Steinberg BE; Goldenberg NM; Taylor K
    J Cardiothorac Vasc Anesth; 2024 Oct; 38(10):2356-2361. PubMed ID: 39095209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.